Global B Streptococcus (GBS) Infection Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Nov-2022
No. of pages: 97
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the B Streptococcus (GBS) Infection Treatment companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional B Streptococcus (GBS) Infection Treatment market. Further, it explains the major drivers and regional dynamics of the global B Streptococcus (GBS) Infection Treatment market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Pfizer Inc.

- Alopexx Pharmaceuticals, LLC

- Wellstat Vaccines LLC

- Minervax ApS

- Novartis

- GlaxoSmithKline

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

B Streptococcus (GBS) Infection Treatment Segment by Type

- Prenatal-onset GBS Disease

- Early-onset GBS Disease

- Late-onset GBS Disease

B Streptococcus (GBS) Infection Treatment Segment by Application

- Hospitals Pharmacies

- Retail Pharmacies

- Online Pharmacies

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the B Streptococcus (GBS) Infection Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for B Streptococcus (GBS) Infection Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of B Streptococcus (GBS) Infection Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for B Streptococcus (GBS) Infection Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the B Streptococcus (GBS) Infection Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global B Streptococcus (GBS) Infection Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for B Streptococcus (GBS) Infection Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer Inc., Alopexx Pharmaceuticals, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc.

Global B Streptococcus (GBS) Infection Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Prenatal-onset GBS Disease
1.2.3 Early-onset GBS Disease
1.2.4 Late-onset GBS Disease
1.3 Market by Application
1.3.1 Global B Streptococcus (GBS) Infection Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global B Streptococcus (GBS) Infection Treatment Market Size (2017-2028)
2.2 B Streptococcus (GBS) Infection Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global B Streptococcus (GBS) Infection Treatment Market Size by Region (2017-2022)
2.4 Global B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2023-2028)
2.5 Global Top B Streptococcus (GBS) Infection Treatment Countries Ranking by Market Size
3 B Streptococcus (GBS) Infection Treatment Competitive by Company
3.1 Global B Streptococcus (GBS) Infection Treatment Revenue by Players
3.1.1 Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2017-2022)
3.1.2 Global B Streptococcus (GBS) Infection Treatment Market Share by Players (2017-2022)
3.2 Global B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by B Streptococcus (GBS) Infection Treatment Revenue
3.4 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
3.4.1 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B Streptococcus (GBS) Infection Treatment Revenue in 2021
3.5 Global B Streptococcus (GBS) Infection Treatment Key Players Head office and Area Served
3.6 Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
3.7 Date of Enter into B Streptococcus (GBS) Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global B Streptococcus (GBS) Infection Treatment Breakdown Data by Type
4.1 Global B Streptococcus (GBS) Infection Treatment Historic Revenue by Type (2017-2022)
4.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Revenue by Type (2023-2028)
5 Global B Streptococcus (GBS) Infection Treatment Breakdown Data by Application
5.1 Global B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2017-2022)
5.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
6.2 North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
6.3 North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
6.4 North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
7.2 Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
7.3 Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
7.4 Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
8.2 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
8.3 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
8.4 Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
9.2 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
9.3 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
9.4 Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022)
10.2 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2028)
10.3 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2028)
10.4 Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Products and Services
11.1.4 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.1.5 Pfizer Inc. B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.1.6 Pfizer Inc. Recent Developments
11.2 Alopexx Pharmaceuticals, LLC
11.2.1 Alopexx Pharmaceuticals, LLC Company Details
11.2.2 Alopexx Pharmaceuticals, LLC Business Overview
11.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Products and Services
11.2.4 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.2.5 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.2.6 Alopexx Pharmaceuticals, LLC Recent Developments
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Details
11.3.2 Wellstat Vaccines LLC Business Overview
11.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Products and Services
11.3.4 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.3.5 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.3.6 Wellstat Vaccines LLC Recent Developments
11.4 Minervax ApS
11.4.1 Minervax ApS Company Details
11.4.2 Minervax ApS Business Overview
11.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Products and Services
11.4.4 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.4.5 Minervax ApS B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.4.6 Minervax ApS Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis B Streptococcus (GBS) Infection Treatment Products and Services
11.5.4 Novartis B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.5.5 Novartis B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Products and Services
11.6.4 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
11.6.5 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment SWOT Analysis
11.6.6 GlaxoSmithKline Recent Developments
12 B Streptococcus (GBS) Infection Treatment Market Dynamics
12.1 B Streptococcus (GBS) Infection Treatment Market Trends
12.2 B Streptococcus (GBS) Infection Treatment Market Drivers
12.3 B Streptococcus (GBS) Infection Treatment Market Challenges
12.4 B Streptococcus (GBS) Infection Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Prenatal-onset GBS Disease
Table 3. Key Players of Early-onset GBS Disease
Table 4. Key Players of Late-onset GBS Disease
Table 5. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global B Streptococcus (GBS) Infection Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Region (2017-2022)
Table 9. Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global B Streptococcus (GBS) Infection Treatment Market Share by Players (2017-2022)
Table 11. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2021)
Table 12. Ranking of Global Top B Streptococcus (GBS) Infection Treatment Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
Table 16. Date of Key Manufacturers Enter into B Streptococcus (GBS) Infection Treatment Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global B Streptococcus (GBS) Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2022)
Table 20. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2023-2028)
Table 22. Global B Streptococcus (GBS) Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2022)
Table 24. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2023-2028)
Table 26. North America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 61. Pfizer Inc. Company Details
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product and Services
Table 64. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 65. Pfizer Inc. B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 66. Pfizer Inc. Recent Developments
Table 67. Alopexx Pharmaceuticals, LLC Company Details
Table 68. Alopexx Pharmaceuticals, LLC Business Overview
Table 69. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product and Services
Table 70. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 71. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 72. Alopexx Pharmaceuticals, LLC Recent Developments
Table 73. Wellstat Vaccines LLC Company Details
Table 74. Wellstat Vaccines LLC Business Overview
Table 75. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product and Services
Table 76. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 77. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 78. Wellstat Vaccines LLC Recent Developments
Table 79. Minervax ApS Company Details
Table 80. Minervax ApS Business Overview
Table 81. Minervax ApS B Streptococcus (GBS) Infection Treatment Product and Services
Table 82. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 83. Minervax ApS B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 84. Minervax ApS Recent Developments
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis B Streptococcus (GBS) Infection Treatment Product and Services
Table 88. Novartis B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 89. Novartis B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 90. Novartis Recent Developments
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product and Services
Table 94. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue in B Streptococcus (GBS) Infection Treatment Business (2017-2022) & (US$ Million)
Table 95. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment SWOT Analysis
Table 96. GlaxoSmithKline Recent Developments
Table 97. B Streptococcus (GBS) Infection Treatment Market Trends
Table 98. B Streptococcus (GBS) Infection Treatment Market Drivers
Table 99. B Streptococcus (GBS) Infection Treatment Market Challenges
Table 100. B Streptococcus (GBS) Infection Treatment Market Restraints
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B Streptococcus (GBS) Infection Treatment Sales Market Share by Type: 2021 VS 2028
Figure 2. Prenatal-onset GBS Disease Features
Figure 3. Early-onset GBS Disease Features
Figure 4. Late-onset GBS Disease Features
Figure 5. Global B Streptococcus (GBS) Infection Treatment Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 10. Global B Streptococcus (GBS) Infection Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global B Streptococcus (GBS) Infection Treatment Market Size 2017-2028 (US$ Million)
Figure 12. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 B Streptococcus (GBS) Infection Treatment Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global B Streptococcus (GBS) Infection Treatment Market Share by Players in 2021
Figure 16. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue in 2021
Figure 18. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 19. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 20. North America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 21. North America B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 22. U.S. B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 23. Canada B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 24. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 25. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 26. Europe B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 27. Europe B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 28. Germany B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 29. France B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 31. Italy B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 32. Russia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 34. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific B Streptococcus (GBS) Infection Treatment Revenue Share by Region (2017-2028)
Figure 37. China B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 38. Japan B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 40. India B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 41. Australia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 49. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 50. Latin America B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 51. Latin America B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 52. Mexico B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa B Streptococcus (GBS) Infection Treatment Revenue Share by Country (2017-2028)
Figure 59. Turkey B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. UAE B Streptococcus (GBS) Infection Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. Pfizer Inc. Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 63. Alopexx Pharmaceuticals, LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 64. Wellstat Vaccines LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 65. Minervax ApS Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 66. Novartis Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 67. GlaxoSmithKline Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs